Sookjin Lee
Chief Business Officer (CBO) | Ph.D.
A business expert leading innovation in precision medicine and genomics for 20 years. Accelerating the commercialization of innovative technologies with academic expertise and market insight.
Reproductive Genetic Carrier Screening (RGCS): When and Who to Recommend It To — A Clinical Guide from 5 Year Outcome Data2026. 07. 02
Genomic Newborn Screening (gNBS) Caught 8 Cases Conventional Tests Missed — A 9,992-Newborn WGS Cohort From Qingdao2026. 06. 27
[Clinical Insight] “Rarely Diagnosed, Not Rare” – An Interview with Dr. Dmytro Tokariev2026. 06. 26
Hereditary Cancer Germline Testing Across 21 European Countries: Why the Same Patient Can Receive a Different Diagnosis2026. 06. 21
How AI Prediction Tools Are Changing Rare Disease Diagnosis — ACMG PP3 Evidence Strength, REVEL, and 3Cnet2026. 06. 08
JAMA Asks: Why Does Diagnosis Still Take Five Years?2026. 05. 19